Characteristics | Â | pre-chemotherapy fibrinogen | pre-chemotherapy fibrinogen | ||
---|---|---|---|---|---|
 | N (%) | (g/L) (mean ± SD) | p value | (g/L) (mean ± SD) | p value |
Age | Â | Â | Â | Â | Â |
<60 | 95(59.4 %) | 4.58 ± 1.28 | 0.053 | 4.44 ± 1.27 | 0.018 |
≥60 | 65(40.6 %) | 5.06 ± 1.65 |  | 4.79 ± 1.27 |  |
gender | Â | Â | Â | Â | Â |
Male | 102(63.8 %) | 4.91 ± 1.53 | 0.041 | 4.72 ± 1.21 | 0.023 |
Female | 58(36.2 %) | 4.40 ± 1.29 |  | 4.34 ± 1.25 |  |
Stage | Â | Â | Â | Â | Â |
III | 60(37.5 %) | 4.895 ± 1.68 | 0.497 | 4.61 ± 1.35 | 0.851 |
IV | 100(62.5 %) | 4.639 ± 1.32 |  | 4.57 ± 1.24 |  |
Histological type | Â | Â | Â | Â | Â |
Adenocarcinoma | 98(61.2 %) | 4.69 ± 1.41 | 0.358 | 4.60 ± 1.28 | 0.677 |
Squamous carcinoma | 34(21.3 %) | 5.06 ± 1.72 |  | 4.36 ± 1.16 |  |
Others | 28(17.5 %) | 4.41 ± 1.28 |  | 4.78 ± 1.39 |  |
ECOG | Â | Â | Â | Â | Â |
0 | 105(65.6 %) | 4.55 ± 1.38 | 0.051 | 4.33 ± 1.11 | 0.002 |
1 | 55(34.4 %) | 5.04 ± 1.57 |  | 5.07 ± 1.44 |  |